407 related articles for article (PubMed ID: 20181491)
21. Cytokines in chronic obstructive pulmonary disease.
Chung KF
Eur Respir J Suppl; 2001 Dec; 34():50s-59s. PubMed ID: 12392035
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
23. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Wang YZ; Liu XF; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264
[TBL] [Abstract][Full Text] [Related]
24. Correlation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patients.
Ziora D; Dworniczak S; Kaczmarczyk G; Jastrzebski D; Krzywiecki A; Kozielski J
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):791-9. PubMed ID: 18204193
[TBL] [Abstract][Full Text] [Related]
25. Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis.
Guran T; Ersu R; Karadag B; Akpinar IN; Demirel GY; Hekim N; Dagli E
Pediatr Pulmonol; 2007 Apr; 42(4):362-9. PubMed ID: 17351928
[TBL] [Abstract][Full Text] [Related]
26. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease.
Gessner C; Scheibe R; Wötzel M; Hammerschmidt S; Kuhn H; Engelmann L; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2005 Oct; 99(10):1229-40. PubMed ID: 16140223
[TBL] [Abstract][Full Text] [Related]
27. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
28. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
[TBL] [Abstract][Full Text] [Related]
29. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.
Dentener MA; Vernooy JH; Hendriks S; Wouters EF
Thorax; 2005 Feb; 60(2):114-9. PubMed ID: 15681498
[TBL] [Abstract][Full Text] [Related]
30. Effects of a short-term rehabilitation program on airway inflammation in children with cystic fibrosis.
Moeller A; Stämpfli SF; Rueckert B; Rechsteiner T; Hamacher J; Wildhaber JH
Pediatr Pulmonol; 2010 Jun; 45(6):541-51. PubMed ID: 20503278
[TBL] [Abstract][Full Text] [Related]
31. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis].
Peng H; Chen P; Cai S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):351-4. PubMed ID: 11802988
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
[TBL] [Abstract][Full Text] [Related]
33. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
34. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
35. A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosis.
Reeves EP; Bergin DA; Fitzgerald S; Hayes E; Keenan J; Henry M; Meleady P; Vega-Carrascal I; Murray MA; Low TB; McCarthy C; O'Brien E; Clynes M; Gunaratnam C; McElvaney NG
J Cyst Fibros; 2012 Mar; 11(2):100-7. PubMed ID: 22035905
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
37. Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease.
Gessner C; Hammerschmidt S; Kuhn H; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2007 Nov; 101(11):2271-8. PubMed ID: 17693071
[TBL] [Abstract][Full Text] [Related]
38. Monocyte chemoattractant chemokines in cystic fibrosis.
Rao S; Wright AK; Montiero W; Ziegler-Heitbrock L; Grigg J
J Cyst Fibros; 2009 Mar; 8(2):97-103. PubMed ID: 19000946
[TBL] [Abstract][Full Text] [Related]
39. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
40. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
